{"filing":{"accession_number":"0001193125-26-232707","cik":"0000059478","ticker":"LLY","company_name":"ELI LILLY \u0026 Co","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"d148580d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/59478/000119312526232707/d148580d8k.htm"},"events":[{"id":9811,"run_id":8603,"accession_number":"0001193125-26-232707","anchor_item_number":"8.01","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"summary":"Eli Lilly completed a substantial $8.94 billion debt offering across eight series of notes with varying maturities and interest rates, including a contingent mandatory redemption provision tied to the Centessa Acquisition. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit neatly into the standard 8-K taxonomy (not an earnings release, M\u0026A completion, impairment, or other specifically enumerated event type). The disclosure is material to investors as it reflects significant new debt obligations and conditional redemption terms dependent on an acquisition outcome.","company_name":"ELI LILLY \u0026 Co","ticker":"LLY","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":613,"accession_number":"0001193125-26-232707","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"Eli Lilly completed a substantial $8.94 billion debt offering across eight series of notes with varying maturities and interest rates, including a contingent mandatory redemption provision tied to the Centessa Acquisition. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit neatly into the standard 8-K taxonomy (not an earnings release, M\u0026A completion, impairment, or other specifically enumerated event type). The disclosure is material to investors as it reflects significant new debt obligations and conditional redemption terms dependent on an acquisition outcome.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:47:55.359041+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":613,"accession_number":"0001193125-26-232707","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"Eli Lilly completed a substantial $8.94 billion debt offering across eight series of notes with varying maturities and interest rates, including a contingent mandatory redemption provision tied to the Centessa Acquisition. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit neatly into the standard 8-K taxonomy (not an earnings release, M\u0026A completion, impairment, or other specifically enumerated event type). The disclosure is material to investors as it reflects significant new debt obligations and conditional redemption terms dependent on an acquisition outcome.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:47:55.359041+00:00","company_name":"ELI LILLY \u0026 Co","ticker":"LLY","filing_date":"2026-05-20"}]}